Class of 2024
For seminal contributions to elucidating the mechanism of action of thalidomide analogs in multiple myeloma, characterizing 5q deletions in myelodysplastic syndrome, defining the importance of age-related clonal hematopoiesis in carcinogenesis, and providing critical insights into targeted protein degradation as a therapeutic strategy.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]